Skip Navigation

This Article
Right arrow Full Text Freely available
Right arrow FREE Full Text (PDF) Freely available
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Search for citing articles in:
ISI Web of Science (4)
Right arrowRequest Permissions
Right arrow Disclaimer
Google Scholar
Right arrow Articles by Persu, A.
Right arrow Articles by Devuyst, O.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Persu, A.
Right arrow Articles by Devuyst, O.
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

Nephrol Dial Transplant (2000) 15: 747-750
© 2000 European Renal Association-European Dialysis and Transplant Association


Editorial Comments

Transepithelial chloride secretion and cystogenesis in autosomal dominant polycystic kidney disease

Alexandre Persu and Olivier Devuyst

Division of Nephrology, Université Catholique de Louvain, Medical School, Brussels, Belgium

Introduction

Autosomal dominant polycystic kidney disease (ADPKD) is one of the most common monogenic hereditary diseases (prevalence 1 : 400–1 : 1000). It is characterized by the development of multiple cysts in both kidneys. These cysts grow slowly but steadily, inducing a progressive renal insufficiency which leads, in about half of the patients, to end-stage renal failure at a mean of 55 years. In Western Europe and North America, ADPKD is responsible for 4–10% of the patients requiring renal replacement therapy. Several extrarenal manifestations, including extrarenal cysts, cardiac valvular abnormalities, and arterial aneurysms, contribute to the morbidity and mortality of the disease. Treatment of ADPKD is currently restricted to the control of associated complications such as hypertension or infection [1].

Linkage to two loci named PKD1 and PKD2 was found in about 85 and 15% of the families affected with ADPKD respectively. A third locus is probably involved in . . . [Full Text of this Article]

Transepithelial fluid secretion in ADPKD cysts

Molecular identification of chloride transporters

A model of intracystic fluid secretion

Regulation of cyst fluid accumulation

Towards modifier genes

Conclusion, questions, and perspectives

Acknowledgments

Notes

References


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
Am. J. Physiol. Renal Physiol.Home page
C. M. Turner, B. F. King, K. S. Srai, and R. J. Unwin
Antagonism of endogenous putative P2Y receptors reduces the growth of MDCK-derived cysts cultured in vitro
Am J Physiol Renal Physiol, January 1, 2007; 292(1): F15 - F25.
[Abstract] [Full Text] [PDF]


Home page
Nephrol Dial TransplantHome page
A. Persu, O. El-Khattabi, T. Messiaen, Y. Pirson, D. Chauveau, and O. Devuyst
Influence of ACE (I/D) and G460W polymorphism of {alpha}-adducin in autosomal dominant polycystic kidney disease
Nephrol. Dial. Transplant., October 1, 2003; 18(10): 2032 - 2038.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Renal Physiol.Home page
O. Devuyst and W. B. Guggino
Chloride channels in the kidney: lessons learned from knockout animals
Am J Physiol Renal Physiol, December 1, 2002; 283(6): F1176 - F1191.
[Abstract] [Full Text] [PDF]